Loading...
ROCO
6523
Market cap169mUSD
Nov 12, Last price  
117.50TWD
Name

DR.Wu Skincare Co Ltd

Chart & Performance

D1W1MN
ROCO:6523 chart
P/E
11.11
P/S
4.26
EPS
10.57
Div Yield, %
5.11%
Shrs. gr., 5y
0.05%
Rev. gr., 5y
4.13%
Revenues
1.24b
+9.20%
565,499,000662,809,000865,214,0001,150,595,000936,922,000962,998,0001,014,212,000764,630,0001,106,011,000926,791,0001,137,145,0001,241,755,000
Net income
476m
+12.13%
188,679,000239,244,000228,390,000312,123,000127,255,00024,839,000191,797,000661,110,000296,242,000339,981,000424,733,000476,253,000
CFO
437m
+11.40%
157,782,000176,220,000166,449,000281,054,00093,828,000120,671,000223,552,000300,908,000289,603,000325,829,000392,440,000437,181,000
Dividend
Oct 03, 20242 TWD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Dr. Wu Skincare Co., Ltd. develops and sells skincare and cosmetics products in Taiwan and internationally. The company offers cleansers, masks, toners, serums, lotion/cream/gel, UV/DD creams, and eye care products, as well as makeup and body products. It also provides products for acne and pores, blackheads, dry skin, signs of aging, dull and spotty skin, sensitive skin, whitening, and emergency care. The company offers its products through a network of approximately 2000 sales locations in Mainland China, Myanmar, Thailand, Malaysia, Singapore, Canada, Vietnam, the Philippines, and Japan. Dr. Wu Skincare Co., Ltd. was incorporated in 2003 and is based in Taipei, Taiwan.
IPO date
Apr 30, 2015
Employees
Domiciled in
TW
Incorporated in
TW

Valuation

Title
TWD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT